AU Patent

AU2015247829B2 — Methods for treating hypersomnia

Assigned to BALANCE THERAPEUTICS Inc · Expires 2019-12-05 · 6y expired

What this patent protects

Provided herein are methods, formulations and dosing regimens for treating hypersomnia in a subject. For instance, methods provided herein comprise administering a GABA

USPTO Abstract

Provided herein are methods, formulations and dosing regimens for treating hypersomnia in a subject. For instance, methods provided herein comprise administering a GABA

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: AU2015247829B2
Jurisdiction: AU
Classification: —
Expires: 2019-12-05
Drug substance claim: No
Drug product claim: No
Assignee: BALANCE THERAPEUTICS Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.